Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer

About half of the patients treated with docetaxel in the setting of metastatic castration-resistant prostate cancer (CRPC) are non-responders. Therefore, a marker of response would be beneficial for clinical decision-making. We evaluated class III β-tubulin (βIII-tubulin) expression as a predictor o...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Maahs, Lucas, Sanchez, Bertha E., Gupta, Nilesh, Van Harn, Meredith, Barrack, Evelyn R., Reddy, Prem-veer, Hwang, Clara
格式: Artigo
語言:Inglês
出版: Public Library of Science 2019
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816559/
https://ncbi.nlm.nih.gov/pubmed/31658275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0222510
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍